MMitraTender

DICLOFENAC: GeM business opportunity

Who buys DICLOFENAC on GeM, in which states, how many sellers compete and what wins. Change the filters to match your business.

Live bids: 0Awarded results: 1Live tenders →

What can you do?

GeM categoryDICLOFENAC
About your business

Live bids + bids closed 2025-11-07 – 2026-11-07 (365 days). Includes imported GeM history.

Live bids
0
Closed in period
117
Awarded results
1
Median winning price (L1)
₹1 lakh
Avg bidders per bid
1

Tenders published per month

Last 12 months, matching your filters

0 Dec 2025
0 Jan 2026
0 Feb 2026
5 Mar 2026
14 Apr 2026
16 May 2026
2020 Jun 2026
19 Jul 2026
18 Aug 2026
14 Sept 2026
11 Oct 2026
0 Nov 2026
Show as table
MonthTenders
Dec 20250
Jan 20260
Feb 20260
Mar 20265
Apr 202614
May 202616
Jun 202620
Jul 202619
Aug 202618
Sept 202614
Oct 202611
Nov 20260

How open are these bids?

No EMD needed
78%

based on 116 bids

MSE turnover/experience relaxed
—

based on 0 bids

Reverse auction
0%

based on 115 bids

Turnover, experience, EMD and exemptions come from bid documents and are still sparse; every share shows how many bids it is based on. Results improve as more history is imported.

Top 10: where to work

Ranked by opportunity score (0–100). Open a row to see why.

  1. 1
    DICLOFENAC73/100

    0 live · 1 bidders avg · L1 ₹1 lakh

    Live tenders →Create alert
    Why this score
    Volume
    100
    Momentum
    50
    Low competition (not enough data, neutral)
    50
    Easy criteria
    100
    Order value (not enough data, neutral)
    50
  2. 2
    IBUPROFEN68/100

    0 live

    Live tenders →Create alert
    Why this score
    Volume
    50
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria
    100
    Order value (not enough data, neutral)
    50
  3. 3
    Ceftriaxone64/100

    0 live

    Live tenders →Create alert
    Why this score
    Volume
    38
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria
    100
    Order value (not enough data, neutral)
    50
  4. 4
    PANTOPRAZOLE63/100

    0 live

    Live tenders →Create alert
    Why this score
    Volume
    52
    Momentum
    76
    Low competition (not enough data, neutral)
    50
    Easy criteria
    100
    Order value (not enough data, neutral)
    50
  5. 5
    PARACETAMOL61/100

    0 live

    Live tenders →Create alert
    Why this score
    Volume
    57
    Momentum
    60
    Low competition (not enough data, neutral)
    50
    Easy criteria
    100
    Order value (not enough data, neutral)
    50
  6. 6
    Atropine46/100

    0 live

    Live tenders →Create alert
    Why this score
    Volume
    46
    Momentum
    0
    Low competition (not enough data, neutral)
    50
    Easy criteria
    100
    Order value (not enough data, neutral)
    50
  7. 7
    METRONIDAZOLE43/100

    0 live

    Live tenders →Create alert
    Why this score
    Volume
    34
    Momentum
    0
    Low competition (not enough data, neutral)
    50
    Easy criteria
    100
    Order value (not enough data, neutral)
    50
  8. 8
    AZITHROMYCIN43/100

    0 live

    Live tenders →Create alert
    Why this score
    Volume
    34
    Momentum
    0
    Low competition (not enough data, neutral)
    50
    Easy criteria
    100
    Order value (not enough data, neutral)
    50
  9. 9
    DICLOFENAC SODIUM43/100

    0 live

    Live tenders →Create alert
    Why this score
    Volume
    34
    Momentum
    0
    Low competition (not enough data, neutral)
    50
    Easy criteria
    100
    Order value (not enough data, neutral)
    50
  10. 10
    CEFIXIME41/100

    0 live

    Live tenders →Create alert
    Why this score
    Volume
    29
    Momentum
    0
    Low competition (not enough data, neutral)
    50
    Easy criteria
    100
    Order value (not enough data, neutral)
    50
Show as table
RankNameScoreLive bidsClosed in periodAvg bidders per bidMedian winning price (L1)
1DICLOFENAC7301171₹1 lakh
2IBUPROFEN68010——
3Ceftriaxone6405——
4PANTOPRAZOLE63011——
5PARACETAMOL61014——
6Atropine4608——
7METRONIDAZOLE4304——
8AZITHROMYCIN4304——
9DICLOFENAC SODIUM4304——
10CEFIXIME4103——
How the opportunity score works

Score = Volume 30% + Momentum 20% + Low competition 25% + Easy criteria 15% + Order value 10%. Each part is 0–100; a part without enough data counts as a neutral 50.

  • Volume: tenders in the period, compared with the biggest row of the list.
  • Momentum: share published in the last 30 days vs the average (100 = twice as fast).
  • Low competition: 2 bidders per bid = 100, 15 or more = 0.
  • Easy criteria: share of read bid documents with no EMD, an MSE/startup exemption or no turnover/experience criterion.
  • Order value: median winning (L1) price, compared with the highest in the list.

Who wins these bids

Top L1 sellers in awarded bids of the period

  1. 1 wins

1 different sellers won

Winner names are part of the ₹999 plan and the free trial.

See winner names
Bids won by MSE sellers100%

of 1 awarded bids with the MSE flag

AI business advisor

Get a short plan from these numbers: where to start, whom to sell to, what to prepare and the risks.